Tüm alıştırma soruları

4736 soru

Soru 3241Soru →

Match each of the following ambulatory patient profiles with the single most appropriate guideline-concordant preventive care intervention. Each patient is asymptomatic, has no acute complaints, and has a normal physical examination today.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 41-year-old woman, BMI 23 kg/m², never-smoker. Her last cervical cancer screening with primary HPV testing was at age 38 and was negative.
A 58-year-old man, BMI 26 kg/m², who currently smokes 1 pack of cigarettes daily and has done so for the last 25 years. He had a normal screening colonoscopy at age 52.
A 23-year-old woman, BMI 24 kg/m², non-smoker. She is sexually active with a new male partner. Her last cervical cytology was normal at age 21.
A 66-year-old man, BMI 25 kg/m². He smoked a half-pack of cigarettes daily for 10 years but quit at age 30. He had a normal screening colonoscopy at age 64.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The 41-year-old woman requires screening mammography; the 58-year-old man requires LDCT of the chest; the 23-year-old woman requires chlamydia and gonorrhea screening; and the 66-year-old man requires an abdominal ultrasound for AAA screening.
Each patient requires a specific preventive intervention based on current USPSTF guidelines. The 41-year-old woman needs a mammogram (recommended starting at age 40). The 58-year-old smoker meets all criteria for LDCT (age 50-80, 20+ pack-years). The 23-year-old woman needs STI screening (sexually active, age <25). The 66-year-old former smoker needs an abdominal ultrasound for AAA (men 65-75, any smoking history >100 cigarettes).

Adım Adım Çözüm

1
Analyze the 41-year-old woman's profile.
Identified as due for screening mammography.
Current USPSTF guidelines recommend initiating biennial screening mammography at age 40. Her cervical cancer screening (primary HPV at age 38) is valid for 5 years.
2
Analyze the 58-year-old man's profile.
Identified as due for annual low-dose computed tomography (LDCT) of the chest.
He falls within the 50-80 age range, has a >20 pack-year smoking history, and is a current smoker, meeting all criteria for lung cancer screening. Colorectal screening is not due until age 62.
3
Analyze the 23-year-old woman's profile.
Identified as due for chlamydia and gonorrhea screening.
She is a sexually active woman younger than 25, which is a Grade B indication for STI screening. Her Pap smear (done at 21) is valid for 3 years, so she is not due for cervical cancer screening until age 24.
4
Analyze the 66-year-old man's profile.
Identified as due for a one-time abdominal duplex ultrasound.
He is a man between 65 and 75 years old who has a lifetime smoking history of at least 100 cigarettes (5 pack-years), meeting the criteria for abdominal aortic aneurysm screening.

Anahtar Kavram

Application of USPSTF preventive care guidelines tailored to age, biological sex, and specific clinical risk factors.
Soru 3242Soru →

Paramedics rush a 27-year-old male to the trauma center following a high-speed motorcycle collision. The patient is visibly distressed, confused, and diaphoretic. His temperature is 36.5°C (97.7°F), pulse is 132/min, blood pressure is 84/52 mm Hg, and respiratory rate is 28/min. Pulse oximetry shows 89% on room air. Physical assessment demonstrates leftward tracheal deviation, and breath sounds are absent over the right hemithorax with marked percussion dullness. Intravenous access is rapidly established and volume resuscitation is initiated. A 32-French thoracostomy tube is inserted into the right midaxillary line, yielding an immediate return of 1,600 mL of bright red blood. Over the subsequent 15 minutes, an additional 150 mL drains. The patient's blood pressure remains 82/50 mm Hg despite rapid infusion of 2 L of warmed crystalloid and 1 unit of uncrossmatched packed red blood cells. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Emergent right-sided thoracotomy

Cevap

Emergent right-sided thoracotomy
The correct management for this patient is an emergent right-sided thoracotomy. In the setting of blunt or penetrating thoracic trauma, a massive hemothorax is a life-threatening emergency. The classic indications for urgent thoracotomy include an immediate return of >1,500 mL of blood upon tube thoracostomy insertion, or continuous bleeding of >200 mL/hour for 2 to 4 hours. This patient immediately drained 1,600 mL and remains hemodynamically unstable despite aggressive resuscitation with crystalloids and blood products. Immediate surgical exploration is required to identify and ligate the bleeding source, which is often an intercostal artery, internal mammary artery, or major pulmonary vessel.

Adım Adım Çözüm

1
Assess the patient's hemodynamic status and physical examination findings.
The patient is in hemorrhagic shock with signs of right-sided pleural fluid (dullness, absent breath sounds) and mediastinal shift.
To identify life-threatening thoracic injuries during the primary trauma survey.
2
Evaluate the output from the tube thoracostomy.
An immediate drainage of 1,600 mL of blood is observed, with continued bleeding.
To determine if massive hemothorax criteria for surgery are met.
3
Determine the indication for surgical intervention.
The massive initial blood output (>1,500 mL) combined with persistent hemodynamic instability dictates emergent surgical exploration.
To achieve definitive hemostatic source control and prevent exsanguination.

Anahtar Kavram

Indications for urgent thoracotomy in a patient with a massive hemothorax include an immediate initial chest tube output greater than 1,500 mL or ongoing hemorrhage greater than 200 mL/hour for 2 to 4 hours, particularly in the setting of hemodynamic instability.
Soru 3243Soru →

An established 38-year-old female patient presents for follow-up regarding resistant hypertension. She reports experiencing profound muscle cramps and episodic weakness over the last month. Clinical assessment reveals a blood pressure of 168/102 mm Hg, which has remained uncontrolled despite strict adherence to maximum tolerated doses of lisinopril, amlodipine, and hydrochlorothiazide. A basic metabolic panel highlights a serum potassium level of 2.8 mEq/L. Suspecting primary hyperaldosteronism, the physician tapers her interfering medications, transitions her to doxazosin, and normalizes her potassium. Arrange the subsequent diagnostic investigations in the correct chronological order, proceeding from the initial diagnostic step to the definitive pre-surgical assessment.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: Measurement of plasma aldosterone concentration and plasma renin activity -> Confirmatory sodium suppression test -> High-resolution CT of the adrenal glands -> Adrenal venous sampling.
The correct diagnostic sequence for primary hyperaldosteronism begins with biochemical screening, followed by biochemical confirmation, then anatomical localization, and finally functional lateralization. First, the ratio of plasma aldosterone concentration to plasma renin activity (PAC/PRA) is measured as a highly sensitive screening tool. If elevated, the diagnosis is confirmed by demonstrating inappropriate autonomous aldosterone secretion during a sodium suppression test (such as an intravenous saline infusion). Once the biochemical diagnosis is secure, an adrenal protocol CT scan is performed to visualize the adrenal glands, rule out large suspected carcinomas, and map the venous anatomy. Finally, because non-functioning adrenal nodules are common and imaging alone cannot definitively prove which gland is hypersecreting, adrenal venous sampling (AVS) is performed to differentiate between a unilateral aldosterone-producing adenoma and bilateral adrenal hyperplasia.

Adım Adım Çözüm

1
Perform initial biochemical screening.
Measurement of the plasma aldosterone concentration to plasma renin activity (PAC/PRA) ratio.
A high PAC/PRA ratio is highly sensitive for detecting autonomous aldosterone production and serves as the standard first-line screen.
2
Execute biochemical confirmation.
Confirmatory sodium suppression test (e.g., intravenous saline infusion or oral sodium loading).
Screening tests can yield false positives; therefore, failure to suppress aldosterone levels in the face of a high sodium load confirms the diagnosis.
3
Obtain initial anatomical localization.
High-resolution computed tomography (CT) of the adrenal glands.
Imaging is required to exclude large malignant masses and to provide an anatomical roadmap of the adrenal veins for the interventional radiologist.
4
Perform functional lateralization.
Adrenal venous sampling (AVS).
Imaging cannot distinguish between a functional unilateral adenoma and a non-functioning incidentaloma with concurrent bilateral hyperplasia; AVS is required to prove lateralization before surgery.

Anahtar Kavram

The diagnostic workup for primary hyperaldosteronism follows a strict sequential algorithm: Screen (PAC/PRA) -> Confirm (Sodium suppression) -> Localize (Adrenal CT) -> Lateralize (Adrenal Venous Sampling).
Tahmini Süre:1m 30s
Soru 3244Soru →

A 72-year-old man comes to the clinic for a routine follow-up. He has a history of ischemic cardiomyopathy with a severely reduced left ventricular ejection fraction and recurrent, symptomatic ventricular tachycardia. He was started on amiodarone two years ago, which has successfully suppressed his arrhythmias. Over the past three months, the patient has developed progressive fatigue, increased sensitivity to cold, and a weight gain of 4.5 kg4.5\text{ kg} (9.9 lbs9.9\text{ lbs}). His other medications include lisinopril, metoprolol succinate, and aspirin. Vital signs show a blood pressure of 118/74 mmHg118/74\text{ mmHg} and a heart rate of 62/min62/\text{min}. Physical examination reveals delayed relaxation of the deep tendon reflexes.

Laboratory studies reveal:
Thyroid-stimulating hormone (TSH): 18.4 μU/mL18.4\text{ }\mu\text{U/mL} (Reference: 0.4−4.0 μU/mL0.4-4.0\text{ }\mu\text{U/mL})
Free T4: 0.5 ng/dL0.5\text{ ng/dL} (Reference: 0.9−1.7 ng/dL0.9-1.7\text{ ng/dL})

Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Continue amiodarone and begin levothyroxine therapy

Cevap

Continue amiodarone and begin levothyroxine therapy
The correct approach for amiodarone-induced hypothyroidism is to continue the amiodarone and administer exogenous levothyroxine. Amiodarone is highly efficacious for ventricular tachycardia, and its discontinuation in a patient with ischemic cardiomyopathy could result in fatal arrhythmias. Because amiodarone contains a large amount of iodine, it can induce hypothyroidism via the Wolff-Chaikoff effect (failure of the thyroid to escape the acute inhibitory effect of excess iodine on hormone synthesis). This side effect is easily and safely managed with levothyroxine supplementation.

Adım Adım Çözüm

1
Analyze the patient's symptoms and laboratory results.
The patient exhibits fatigue, cold intolerance, weight gain, delayed reflexes, elevated TSH, and low free T4.
To establish the diagnosis of primary hypothyroidism.
2
Identify the underlying etiology of the hypothyroidism.
The hypothyroidism is an adverse effect of amiodarone, a medication with high iodine content that can inhibit thyroid hormone synthesis (Wolff-Chaikoff effect).
To determine if the etiology is related to the patient's pharmacological regimen.
3
Formulate a treatment plan that balances endocrine management with cardiovascular stability.
Initiate levothyroxine to treat the hypothyroidism while continuing amiodarone.
Amiodarone is effectively suppressing life-threatening ventricular tachycardia in a patient with ischemic cardiomyopathy. The endocrine side effect can be safely managed with exogenous hormone replacement without compromising arrhythmia control.

Anahtar Kavram

Patients who develop amiodarone-induced hypothyroidism should typically continue amiodarone (especially if it is controlling life-threatening arrhythmias) and be treated simultaneously with levothyroxine replacement therapy.
Tahmini Süre:1m 15s
Soru 3245Soru →

A 6262-year-old man with a 1010-year history of type 2 diabetes mellitus returns to the clinic for a routine follow-up. His current medication regimen includes maximum tolerated doses of metformin, empagliflozin, and a glucagon-like peptide-1 (GLP-1) receptor agonist. His hemoglobin A1c today is 9.5%9.5\%, and his home fasting blood glucose levels consistently range between 180180 and 220 mg/dL220\text{ mg/dL}. The physician and patient agree that initiating insulin therapy is the most appropriate next step. Arrange the following steps in the correct chronological sequence for intensifying and monitoring this patient's insulin therapy over the coming months according to standard diabetes care guidelines.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: (1) Initiate a once-daily basal insulin injection, (2) Titrate the basal insulin dose based on fasting blood glucose monitoring, (3) Assess postprandial blood glucose levels if HbA1c remains unmet, and (4) Add a single injection of rapid-acting prandial insulin before the largest meal.
The American Diabetes Association (ADA) recommends a stepwise approach to insulin intensification in type 2 diabetes. When oral agents and GLP-1 receptor agonists are insufficient, the first step is to initiate basal insulin. The basal dose is then systematically titrated based on fasting blood glucose readings until the fasting target is achieved. If the fasting target is met but the hemoglobin A1c remains above the individualized goal, this indicates that postprandial excursions are driving the persistent hyperglycemia. Therefore, the next step in treatment evaluation is to monitor postprandial blood glucose levels. Once postprandial hyperglycemia is confirmed, the treatment is further intensified by adding a dose of rapid-acting prandial insulin, usually starting with the largest or most carbohydrate-heavy meal of the day.

Adım Adım Çözüm

1
Address the high fasting blood glucose.
Initiate basal insulin.
Basal insulin targets fasting hyperglycemia, which is the primary driver of HbA1c elevation in this range.
2
Evaluate and optimize the initial therapy.
Titrate basal insulin.
The initial basal dose must be adjusted upward until the fasting blood glucose reaches the therapeutic target (typically 8080 to 130 mg/dL130\text{ mg/dL}).
3
Investigate persistent overall hyperglycemia (elevated HbA1c) despite achieving fasting targets.
Measure postprandial blood glucose.
If fasting levels are normal but HbA1c is high, postprandial excursions are the likely cause and must be documented.
4
Intensify therapy to address postprandial excursions.
Add rapid-acting prandial insulin.
A single dose of prandial insulin before the largest meal directly mitigates the identified postprandial hyperglycemia, completing the stepwise approach.

Anahtar Kavram

The stepwise approach to initiating, monitoring, and intensifying insulin therapy in type 2 diabetes mellitus.
Soru 3246Soru →

Match each patient's clinical presentation with the most appropriate next step in diagnostic evaluation and testing sequence.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 62-year-old patient evaluating for stable exertional angina who has an uninterpretable baseline electrocardiogram due to a complete left bundle branch block.
A 32-year-old patient with acute pleuritic chest pain and tachypnea, a normal baseline chest radiograph, and a documented severe anaphylactic allergy to iodinated contrast media.
A 45-year-old patient with generalized pruritus, fatigue, and an isolated marked elevation of alkaline phosphatase whose right upper quadrant ultrasound shows no biliary ductal dilation.
A 24-year-old patient with acute-onset high fever, nuchal rigidity, and severe headache, who has a normal level of consciousness, no focal neurologic deficits, and no papilledema.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct pairings align pre-test clinical constraints with established diagnostic algorithms: complete LBBB requires pharmacologic stress imaging; iodinated contrast allergy with a normal chest radiograph requires V/Q scanning; intrahepatic cholestasis without ductal dilation requires anti-mitochondrial antibody testing; and classic meningitis symptoms without high-risk neurologic features require immediate lumbar puncture without a prior CT scan.
Each pairing represents the most efficient, cost-effective, and safe diagnostic step for the specific clinical constraints presented. The matching relies on bypassing conventional first-line tests when contraindications exist (e.g., LBBB preventing standard exercise ECG, contrast allergy preventing CTPA) or following standard algorithmic progression (e.g., a negative ultrasound leading to serologic testing for primary biliary cholangitis; the absence of high-risk neurological features allowing direct lumbar puncture).

Adım Adım Çözüm

1
Analyze the baseline diagnostic constraints and prior test results for each patient scenario.
Identified key limiting factors: complete LBBB, anaphylaxis to contrast, lack of biliary dilation on ultrasound, and absence of 'red flag' neurological signs.
Accurate test sequencing heavily depends on recognizing absolute contraindications or prerequisites for standard first-line investigations.
2
Determine the appropriate guideline-directed alternative or subsequent diagnostic test based on the identified constraints.
Selected pharmacologic stress testing, V/Q scan, AMA titers, and direct lumbar puncture respectively.
Bypassing contraindicated initial tests or proceeding efficiently with the next algorithmic step prevents misdiagnosis, avoids unnecessary healthcare costs, and prevents treatment delays.

Anahtar Kavram

Clinical algorithms for diagnostic test sequencing frequently require modification based on baseline patient characteristics, absolute contraindications to specific modalities, and the presence or absence of exclusionary criteria.
Soru 3247Soru →

Match the following clinical presentations evaluated in the emergency department to the most appropriate initial disposition care setting.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 58-year-old man with refractory angina, positive cardiac biomarkers, and dynamic ischemic electrocardiogram changes despite maximum intravenous medical therapy.
A 71-year-old woman with a chronic obstructive pulmonary disease exacerbation who is stabilizing on continuous positive airway pressure (CPAP) but requires frequent respiratory assessments.
A 65-year-old man with acute decompensated heart failure who is hemodynamically stable but requires ongoing intravenous diuresis and continuous cardiac telemetry.
A 48-year-old woman presenting with atypical chest pain and normal serial electrocardiograms and troponins, who requires provocative stress testing before definitive clearance.
A 35-year-old man with pleuritic chest pain diagnosed as viral pleurisy, with normal vital signs, a normal electrocardiogram, and well-controlled pain on oral nonsteroidal anti-inflammatory drugs.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct dispositions map high-risk ischemia to the Intensive Care Unit, non-invasive ventilation requirements to a Step-down Unit, stable intravenous diuresis to the General Medical Ward, brief risk stratification to an Observation Unit, and stable, non-life-threatening conditions to Home Discharge.
Appropriate disposition ensures patient safety while optimizing healthcare resource utilization. Patients with refractory ischemia require intensive care for potential rapid deterioration and advanced interventions. Patients on continuous non-invasive ventilation require intermediate (step-down) care for close respiratory monitoring and frequent nursing assessments. Hemodynamically stable patients on routine intravenous therapies are appropriate for general medical wards. Observation units are specifically designed for short-term, protocol-driven risk stratification (e.g., ruling out acute coronary syndrome), while stable, low-risk patients can safely follow up in the outpatient setting.

Adım Adım Çözüm

1
Evaluate hemodynamic stability, oxygenation status, and the need for life-sustaining interventions for each patient.
Identifies patients requiring high-acuity interventions (Intensive Care or Step-down units).
Determines the maximum level of nursing care, continuous monitoring, and physician presence required to prevent adverse events.
2
Assess the need for ongoing inpatient therapeutic management versus diagnostic risk stratification.
Separates patients needing full inpatient admission (e.g., intravenous diuresis) from those needing brief monitoring and testing (Observation Unit).
Prevents unnecessary utilization of full inpatient beds and prolonged hospital stays for patients only requiring short-term evaluation.
3
Identify patients meeting criteria for safe outpatient management.
Determines which patients can be discharged home immediately.
Ensures safe transitions of care while avoiding unnecessary hospitalizations, minimizing healthcare costs, and reducing nosocomial risks.

Anahtar Kavram

Triage and disposition decisions rely on matching a patient's physiologic stability, nursing care intensity requirements, and need for acute interventions with the capabilities of the receiving care setting.
Soru 3248Soru →

A 78-year-old man is evaluated in the intensive care unit for a new-onset fever. He was admitted 4 days ago for severe community-acquired pneumonia and currently requires mechanical ventilation and continuous norepinephrine infusion to maintain adequate perfusion. His past medical history is significant for severe chronic obstructive pulmonary disease and ischemic cardiomyopathy with an ejection fraction of 25%25\%. Temperature is 39.2∘C39.2^\circ\text{C} (102.6∘F102.6^\circ\text{F}), blood pressure is 90/60 mmHg90/60\text{ mmHg} (on vasopressors), pulse is 115/min115/\text{min}, and respirations are fully supported by the ventilator. Physical examination reveals a sedated patient who grimaces and guards when deep palpation is applied to the right upper quadrant. Laboratory studies show a leukocyte count of 22,000/μL22,000/\mu\text{L}, total bilirubin of 1.8 mg/dL1.8\text{ mg/dL}, and alkaline phosphatase of 210 U/L210\text{ U/L}. Aminotransferase levels are within normal limits. A right upper quadrant ultrasound demonstrates a markedly distended gallbladder with a wall thickness of 6 mm6\text{ mm}, pericholecystic fluid, and biliary sludge, but no gallstones are visualized. Which of the following is the most appropriate next step in the management of this patient's abdominal condition?

Cevabı ve açıklamayı göster

Cevap: Placement of a percutaneous cholecystostomy tube

Cevap

Placement of a percutaneous cholecystostomy tube is the correct management step.
This patient has developed acute acalculous cholecystitis, a highly morbid condition typically seen in critically ill, hospitalized patients (e.g., those requiring mechanical ventilation, vasopressors, or total parenteral nutrition). The lack of enteral feeding leads to biliary stasis, ischemia, and subsequent inflammation. Prompt source control is necessary to prevent gallbladder necrosis, gangrene, and perforation. While cholecystectomy is the definitive treatment, this patient is hemodynamically unstable, dependent on a ventilator, and has severe underlying cardiac disease, making him an extremely poor surgical candidate. In such high-risk patients, percutaneous cholecystostomy tube placement is the preferred procedural intervention. It effectively decompresses the infected gallbladder and provides source control under local anesthesia, bridging the patient to definitive surgery once they recover or serving as a definitive treatment if they remain unfit for surgery.

Adım Adım Çözüm

1
Diagnose the acute condition based on clinical and ultrasound findings.
The patient has acute acalculous cholecystitis, characterized by fever, leukocytosis, right upper quadrant tenderness, and ultrasound findings of gallbladder wall thickening and pericholecystic fluid without gallstones in the setting of critical illness.
Establishing the correct diagnosis guides the urgency and type of intervention.
2
Evaluate the patient's surgical risk and hemodynamic stability.
The patient is on vasopressors, requires mechanical ventilation, and has a severe ischemic cardiomyopathy (EF 25%25\%), making him a prohibitively high-risk candidate for surgical intervention under general anesthesia.
Surgical risk stratification determines whether definitive treatment (cholecystectomy) or a temporizing, minimally invasive measure is required.
3
Select the safest procedural intervention for source control.
Percutaneous cholecystostomy tube placement provides necessary gallbladder decompression and source control without the hemodynamic stress of surgery.
Critically ill patients with acalculous cholecystitis require drainage to prevent gallbladder necrosis and perforation.

Anahtar Kavram

In critically ill patients who develop acute acalculous cholecystitis and are poor surgical candidates, placement of a percutaneous cholecystostomy tube is the most appropriate procedural intervention for source control.
Soru 3249Soru →

Emergency medical services bring a 55-year-old woman to the emergency department due to a severe, sudden-onset headache. The patient reports that the pain struck her abruptly 12 hours prior to arrival, describing it as feeling like she was "hit by a lightning bolt." She notes accompanying photophobia and nausea but denies any preceding trauma or fever. Her past medical history includes hypertension managed with amlodipine. Upon arrival, her blood pressure is 168/95 mmHg, pulse is 94/min, and temperature is 37.1°C (98.8°F). Physical examination shows a distressed patient clutching her head. A neurologic assessment reveals mild nuchal rigidity but intact cranial nerves and no focal motor or sensory deficits. A non-contrast computed tomography (CT) scan of the brain is obtained and demonstrates no intracranial hemorrhage, mass effect, or midline shift. Which of the following is the most appropriate next step in diagnostic evaluation?

Cevabı ve açıklamayı göster

Cevap: Lumbar puncture

Cevap

The correct answer is to perform a lumbar puncture.
The correct sequence of diagnostic testing for a suspected subarachnoid hemorrhage begins with a non-contrast head CT. While highly sensitive within the first 6 hours of symptom onset, the sensitivity of a CT scan drops significantly thereafter. Because this patient's symptoms began 12 hours ago, the negative CT scan does not definitively rule out a subarachnoid hemorrhage. Therefore, the mandatory next step in the diagnostic sequence is a lumbar puncture to analyze the cerebrospinal fluid for red blood cells and xanthochromia (bilirubin resulting from hemoglobin breakdown).

Adım Adım Çözüm

1
Identify the primary clinical syndrome based on the patient's presentation.
The patient has a sudden-onset "thunderclap" headache with nuchal rigidity, which is highly suspicious for a subarachnoid hemorrhage (SAH).
Recognizing the hallmark symptoms of life-threatening conditions is the first step in determining the correct diagnostic pathway.
2
Evaluate the results of the initial diagnostic testing in the context of the timeline.
The initial non-contrast head CT is negative; however, it was performed 12 hours after symptom onset, at which point CT sensitivity for acute SAH is significantly reduced.
Understanding the temporal limitations of imaging modalities is critical for deciding if further testing is required to rule out a diagnosis.
3
Determine the appropriate guideline-directed next step in the diagnostic sequence.
Cerebrospinal fluid analysis must be performed to check for red blood cells and xanthochromia.
When a high-risk diagnosis cannot be confidently excluded by initial screening due to temporal factors, the definitive sequential test must be utilized.

Anahtar Kavram

In patients with a high clinical suspicion for subarachnoid hemorrhage and a negative non-contrast head CT (especially greater than 6 hours from symptom onset), a lumbar puncture is required as the sequential next step to definitively evaluate for the presence of blood or xanthochromia.
Soru 3250Soru →

Match each patient presentation in the primary care setting with the single most appropriate, guideline-concordant preventive care intervention.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

31-year-old patient presenting for a routine evaluation who has never been previously tested for HIV
29-year-old pregnant patient at 28 weeks gestation, up to date on all childhood vaccines
46-year-old asymptomatic patient with no family history of gastrointestinal malignancy
41-year-old patient with no significant past medical history who has never been tested for hepatitis C

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Each patient profile correctly maps to its specific, guideline-indicated preventive screening or immunization according to current USPSTF and ACIP age and risk criteria.
The correct pairings directly apply the most current, evidence-based recommendations from the USPSTF and ACIP. The 31-year-old requires one-time HIV screening; the pregnant patient requires a Tdap vaccine in the third trimester; the 46-year-old requires the initiation of colorectal cancer screening; and the 41-year-old requires one-time HCV screening.

Adım Adım Çözüm

1
Analyze the 31-year-old patient's preventive care needs.
Identified requirement for HIV screening.
All adults aged 15 to 65 years require at least one-time HIV screening.
2
Evaluate the 29-year-old pregnant patient's gestational age and vaccination needs.
Identified indication for Tdap administration.
Tdap must be given during every pregnancy at 27-36 weeks to maximize passive antibody transfer to the infant.
3
Assess the 46-year-old asymptomatic patient's age-related cancer screening requirements.
Identified indication for colorectal cancer screening.
Recent guideline updates lowered the starting age for average-risk colorectal cancer screening from 50 to 45 years.
4
Determine the infectious disease screening needs for the 41-year-old patient.
Identified requirement for HCV antibody screening.
Universal one-time HCV screening is indicated for all adults aged 18 to 79 years, regardless of specific risk factors.

Anahtar Kavram

Preventive Care and Screening Guidelines
Tahmini Süre:1m 0s
Soru 3251Soru →

A 62-year-old woman is brought to the emergency department by her family due to a 2-day history of progressively worsening severe right-sided abdominal pain, high fever, and new-onset confusion. Her past medical history is significant for hypertension and hyperlipidemia. On arrival, her temperature is 39.4∘C39.4^\circ\text{C} (102.9∘F102.9^\circ\text{F}), blood pressure is 84/52 mm Hg84/52\text{ mm Hg}, heart rate is 122/min122/\text{min}, and respiratory rate is 24/min24/\text{min}. Physical examination reveals marked scleral icterus, dry mucous membranes, and significant tenderness to palpation in the right upper quadrant without rebound or guarding. The patient is lethargic and disoriented to time and place. Laboratory studies show a leukocyte count of 18,500/mm318,500/\text{mm}^3, a total bilirubin of 6.2 mg/dL6.2\text{ mg/dL}, direct bilirubin of 4.8 mg/dL4.8\text{ mg/dL}, and an alkaline phosphatase of 450 U/L450\text{ U/L}. Arrange the following management steps in the most appropriate chronological sequence for this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: initial stabilization with IV fluids and antibiotics, followed by a right upper quadrant ultrasound, then urgent ERCP, and finally an elective laparoscopic cholecystectomy.
The patient presents with classic signs of Reynolds pentad (fever, jaundice, right upper quadrant pain, hypotension, and altered mental status), indicating severe acute ascending cholangitis complicated by septic shock. The standard sequence of management for such a surgical emergency begins with immediate patient stabilization, which includes aggressive intravenous fluid resuscitation and broad-spectrum antibiotics to address the septic shock. Once stabilizing measures are initiated, a right upper quadrant ultrasound must be obtained to confirm the diagnosis by visualizing common bile duct dilation and potential choledocholithiasis. Following diagnostic confirmation, urgent biliary decompression is required because medical management alone is inadequate for severe suppurative cholangitis; ERCP is the procedure of choice. Finally, after the patient is stabilized and recovers from the acute illness, an elective laparoscopic cholecystectomy should be performed prior to hospital discharge to prevent recurrent biliary events.

Adım Adım Çözüm

1
Recognize the clinical presentation of severe acute cholangitis.
The patient exhibits Reynolds pentad (fever, right upper quadrant pain, jaundice, hypotension, altered mental status).
Identifying the severity of the condition dictates the urgency of intervention.
2
Prioritize initial hemodynamic stabilization.
Administer isotonic crystalloids and broad-spectrum intravenous antibiotics.
The patient is in septic shock; delaying resuscitation can lead to multiorgan failure and death.
3
Confirm the diagnosis with noninvasive imaging.
Obtain a right upper quadrant abdominal ultrasound.
Ultrasound quickly and safely confirms common bile duct dilation and helps rule out other acute abdominal pathologies.
4
Decompress the biliary tree urgently.
Perform urgent endoscopic retrograde cholangiopancreatography (ERCP).
In severe (suppurative) cholangitis, medical management alone is insufficient, and urgent purulent drainage via ERCP is required.
5
Plan definitive surgical management.
Perform a laparoscopic cholecystectomy.
After the acute episode resolves, removing the source of the gallstones prevents future life-threatening occurrences.

Anahtar Kavram

The management of severe acute ascending cholangitis requires sequential steps: immediate hemodynamic stabilization, noninvasive diagnostic confirmation, urgent biliary decompression, and subsequent definitive surgical care.
Soru 3252Soru →

A 42-year-old woman presents to the outpatient clinic for evaluation of a neck lump she noticed two weeks ago while applying lotion. She denies dysphagia, dysphonia, weight changes, palpitations, tremors, or cold intolerance. Her medical history is unremarkable, and she takes no medications. She has no personal or family history of head or neck radiation or thyroid cancer. Vital signs include a blood pressure of 118/76 mmHg, pulse of 72/min, and temperature of 37.0°C (98.6°F). Physical examination reveals a palpable, 2.5-cm, firm, mobile, non-tender nodule in the right lobe of the thyroid gland. The remainder of the thyroid gland is not enlarged, and there is no cervical lymphadenopathy. Which of the following tests should be ordered as the INITIAL steps in evaluating this patient's nodule? (Select the two most appropriate tests)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Measurement of serum thyroid-stimulating hormone; Thyroid ultrasonography

Cevap

The correct initial steps are the measurement of serum thyroid-stimulating hormone (TSH) and thyroid ultrasonography.
The initial evaluation of any newly discovered thyroid nodule requires two concurrent steps: evaluating the functional status of the thyroid gland and assessing the anatomical characteristics of the nodule. Measurement of serum thyroid-stimulating hormone (TSH) is the most sensitive test for determining thyroid function. Thyroid ultrasonography is the imaging modality of choice to confirm the presence of a nodule, measure its exact dimensions, evaluate for suspicious sonographic features (e.g., solid composition, hypoechogenicity, irregular margins, microcalcifications), and check for abnormal cervical lymph nodes. Together, these two tests dictate the subsequent algorithm, specifically determining whether the patient requires a radionuclide scan or an ultrasound-guided fine-needle aspiration biopsy.

Adım Adım Çözüm

1
Identify the primary clinical problem
The patient presents with an asymptomatic, palpable thyroid nodule with no clinical signs of hyperthyroidism or hypothyroidism.
Establishing the clinical baseline directs whether emergency stabilization or routine diagnostic workup is required.
2
Determine the first-line biochemical evaluation
Select serum TSH measurement.
TSH determines the functional status of the nodule. A low TSH indicates a hyperfunctioning nodule (requiring a radionuclide scan), whereas a normal or high TSH requires risk stratification for malignancy.
3
Determine the first-line anatomical evaluation
Select thyroid ultrasonography.
Ultrasound provides the necessary anatomical details (size, composition, margins, echogenicity, microcalcifications) to stratify the risk of malignancy and determine if a biopsy is indicated.

Anahtar Kavram

The initial concurrent workup of a newly discovered thyroid nodule consists of both a biochemical assessment (serum TSH) and an anatomical assessment (thyroid ultrasonography).
Soru 3253Soru →

During a routine cardiovascular follow-up, a 65-year-old male patient is evaluated for long-term care planning. He was diagnosed with nonvalvular atrial fibrillation three weeks ago and subsequently initiated on apixaban for thromboembolic prevention. His medical history includes hypertension and stage 2 chronic kidney disease. His daily regimen consists of apixaban, lisinopril, and amlodipine. He denies any recent bleeding, unusual bruising, or palpitations. As part of guideline-directed medical therapy, which TWO of the following parameters must be included in his routine, long-term surveillance plan? (Select two)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Assessment of serum creatinine and estimated glomerular filtration rate at least annually; Assessment of hemoglobin and hematocrit at least annually

Cevap

The necessary monitoring parameters are the assessment of serum creatinine and estimated glomerular filtration rate at least annually, and the assessment of hemoglobin and hematocrit at least annually.
Direct oral anticoagulants (DOACs) such as apixaban offer the advantage of predictable pharmacokinetics, thereby eliminating the need for routine monitoring of coagulation times. However, safe long-term use requires specific surveillance. First, because DOACs are partially eliminated via the kidneys, a decline in renal function can lead to drug accumulation and major bleeding; therefore, serum creatinine and estimated glomerular filtration rate (eGFR) must be evaluated at least annually (and more frequently in those with advanced age or established chronic kidney disease). Second, because these agents inherently disrupt hemostasis, patients are at risk for chronic, asymptomatic blood loss (particularly from the gastrointestinal tract). As a result, an annual complete blood count or assessment of hemoglobin and hematocrit is essential to detect occult bleeding early.

Adım Adım Çözüm

1
Identify the primary medication being evaluated and its drug class.
The patient is taking apixaban, which is a direct oral anticoagulant (DOAC) specifically targeting factor Xa.
Different classes of anticoagulants have distinct monitoring requirements and safety profiles.
2
Determine the clearance mechanisms and primary adverse effects associated with this medication class.
Apixaban is partially cleared by the kidneys, and like all anticoagulants, its primary adverse effect is bleeding.
Understanding pharmacokinetics and side effect profiles dictates what organ systems need routine surveillance.
3
Apply guideline-directed surveillance protocols for long-term DOAC therapy.
Guidelines mandate at least annual monitoring of renal function to ensure appropriate dosing, and annual hemoglobin/hematocrit monitoring to detect occult bleeding.
This ensures both continued efficacy (proper dosing) and patient safety over the course of lifelong therapy.

Anahtar Kavram

Patients receiving direct oral anticoagulants (DOACs) require at least annual monitoring of renal function to guide dosing adjustments and annual complete blood counts to screen for occult hemorrhage, but do not require routine coagulation testing.
Soru 3254Soru →

A 78-year-old woman with a history of congestive heart failure and chronic kidney disease is hospitalized for a severe heart failure exacerbation. After a 5-day stay, she has reached clinical stability. The interdisciplinary team is preparing her for transition to a skilled nursing facility (SNF) for subacute rehabilitation. To ensure patient safety, prevent medication errors, and minimize readmission risk, arrange the following steps of the transitions-of-care pathway in the correct chronological sequence according to standard safe discharge practices.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The chronological sequence is: 1) Needs assessment to determine disposition, 2) Medication reconciliation to finalize the regimen, 3) Patient/caregiver education via teach-back, 4) Transmission of the discharge summary to receiving clinicians, and 5) Post-transition telephone outreach.
A safe and effective transition of care pathway follows a logical chronological progression designed to eliminate gaps in patient safety. Early assessment of functional and social needs determines the appropriate disposition setting (e.g., SNF) well before the actual discharge date. As the patient approaches clinical stability, a rigorous medication reconciliation must be performed to finalize the discharge regimen and prevent polypharmacy or omissions. Only after this regimen is finalized can meaningful, teach-back education be provided to the patient and family. At the time of physical transfer, a comprehensive discharge summary must be communicated to the receiving clinicians to ensure immediate continuity of care. Finally, a post-transition outreach call is conducted within 48-72 hours to ensure the plan is being executed safely and to intercept early signs of clinical deterioration.

Adım Adım Çözüm

1
Assess functional status and post-discharge needs.
Determination of the safest disposition setting (SNF).
Disposition planning must begin early in the hospital course to allow adequate time for facility coordination and insurance approval.
2
Complete discharge medication reconciliation.
Generation of an accurate, finalized list of post-discharge medications.
Resolving discrepancies between home medications and hospital therapies prevents adverse drug events and is required before counseling the patient.
3
Provide teach-back education to the patient and family.
Confirmation of patient understanding regarding medications and warning signs.
Patients must understand their finalized care plan before leaving the hospital to prevent early readmissions.
4
Transmit the discharge summary and records to the SNF.
Seamless transfer of medical information to the accepting clinicians.
Receiving providers require immediate access to the reconciled medication list and hospital course summary to safely assume care upon the patient's arrival.
5
Execute post-transition telephone outreach.
Verification of clinical stability and adherence in the new setting.
A systematic follow-up within 48-72 hours identifies gaps in care, such as missing medications or early symptom recurrence, mitigating the risk of readmission.

Anahtar Kavram

Safe transitions of care follow a structured pathway: early disposition assessment, formalized medication reconciliation, teach-back patient education, standardized clinician-to-clinician handoff, and early post-discharge follow-up.
Tahmini Süre:1m 30s
Soru 3255Soru →

A 48-year-old woman comes to the clinic for evaluation of progressive weight gain, fatigue, and easy bruising over the past 8 months. She reports difficulty climbing stairs due to proximal leg weakness. Her medical history is unremarkable, and she takes no medications. Her blood pressure is 162/98 mm Hg, and her pulse is 82/min. Physical examination reveals a plethoric face, prominent supraclavicular fat pads, and broad, violaceous striae over the lower abdomen. Which of the following is the most appropriate next step in the diagnostic evaluation of this patient?

Cevabı ve açıklamayı göster

Cevap: Measurement of late-night salivary cortisol concentration

Cevap

Measurement of late-night salivary cortisol concentration
The correct answer is the measurement of late-night salivary cortisol concentration. This patient presents with classic clinical features of Cushing syndrome. The diagnostic workup for Cushing syndrome must follow a strict sequence to avoid false-positive localizations. The first mandatory step is to biochemically establish the presence of pathological hypercortisolism. This is achieved by utilizing one of three first-line screening tests: late-night salivary cortisol (assessing the loss of normal diurnal variation), 24-hour urine free cortisol (assessing total daily production), or a low-dose (1-mg) overnight dexamethasone suppression test (assessing the loss of normal negative feedback).

Adım Adım Çözüm

1
Identify the clinical syndrome presented by the patient.
The patient exhibits classic signs of Cushing syndrome, including progressive weight gain, proximal muscle weakness, easy bruising, facial plethora, supraclavicular fat pads, broad violaceous striae, and secondary hypertension.
Recognizing the constellation of symptoms dictates the specific diagnostic pathway for hypercortisolism.
2
Determine the first step in the established diagnostic sequence for the suspected condition.
The initial step in evaluating suspected Cushing syndrome is confirming the presence of endogenous hypercortisolism using one of three recommended screening tests.
Biochemical confirmation of the disease state must precede any attempts to localize the source of the hormone excess.
3
Select the appropriate screening test from the available options.
Late-night salivary cortisol is one of the validated initial screening tests. The other options represent tests utilized further down the diagnostic algorithm or inappropriate tests.
Diagnostic test sequencing strictly requires establishing hypercortisolism before measuring ACTH or performing imaging.

Anahtar Kavram

The initial evaluation of suspected Cushing syndrome requires confirming hypercortisolism with a 24-hour urine free cortisol, late-night salivary cortisol, or low-dose dexamethasone suppression test before assessing ACTH levels or performing imaging.
Tahmini Süre:1m 15s
Soru 3256Soru →

A 42-year-old woman is evaluated on hospital day 8 for discharge planning. She was admitted for a severe acute exacerbation of relapsing-remitting multiple sclerosis, which presented with rapid-onset paraparesis, sensory loss below the T10 dermatome, and urinary retention. She completed a 5-day course of high-dose intravenous methylprednisolone followed by plasma exchange. Her medical condition is now stable, and the acute neuroinflammatory process has been halted.

On current examination, she has 5/5 motor strength in her upper extremities and 2/5 strength in both lower extremities. She requires an indwelling urinary catheter. Prior to this exacerbation, she was fully independent, ambulatory, and employed full-time as a teacher. Physical and occupational therapy evaluations indicate that she requires moderate to maximal assistance for bed-to-chair transfers. She is highly motivated, has excellent rehabilitation potential, and has demonstrated the ability to actively participate in comprehensive therapy for at least 3.5 hours per day.

Which of the following is the most appropriate disposition care setting for this patient?

Cevabı ve açıklamayı göster

Cevap: Transfer to an inpatient rehabilitation facility

Cevap

Transfer to an inpatient rehabilitation facility
The correct answer is transfer to an inpatient rehabilitation facility. This patient is medically stable but has severe acute functional deficits (paraparesis) requiring intensive, multidisciplinary rehabilitation (physical and occupational therapy). She meets the strict criteria for an inpatient rehabilitation facility (IRF) because she has excellent functional potential and, crucially, has demonstrated the ability to tolerate at least 3 hours of intensive therapy per day. An IRF provides this high-intensity rehab along with close medical supervision, which is standard of care for severe neuro-inflammatory exacerbations with profound reversible deficits.

Adım Adım Çözüm

1
Assess the patient's current medical stability and acute care needs.
The patient has completed acute treatments (steroids, plasmapheresis) and is medically stable, indicating that acute hospitalization is no longer necessary.
Determining medical stability is the first step in safely transitioning a patient out of the acute inpatient setting.
2
Evaluate the patient's functional status and rehabilitation needs.
The patient has significant functional deficits, including paraparesis and a requirement for maximal assistance with transfers, necessitating a multidisciplinary approach.
Functional status dictates the level of nursing care and therapy required post-discharge.
3
Determine the appropriate post-acute care setting based on therapy tolerance.
The patient can tolerate and benefit from intensive therapy (>3 hours per day), making an inpatient rehabilitation facility the correct disposition.
The ability to tolerate 3 or more hours of daily multidisciplinary therapy is the primary criterion distinguishing an inpatient rehabilitation facility from a skilled nursing facility.

Anahtar Kavram

Inpatient Rehabilitation Facility (IRF) Admission Criteria
Soru 3257Soru →

A 52-year-old woman is hospitalized for a massive pulmonary embolism and treated with a continuous unfractionated heparin infusion. On hospital day 66, her platelet count decreases from an admission baseline of 260,000/mm3260,000/\text{mm}^3 to 85,000/mm385,000/\text{mm}^3. She subsequently reports acute left lower extremity pain, and a duplex ultrasound confirms a new deep vein thrombosis. Her clinical presentation yields a 4T score indicating a high probability of heparin-induced thrombocytopenia (HIT). Arrange the following therapeutic management and monitoring steps in the correct chronological sequence.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is to first discontinue heparin, immediately start a non-heparin anticoagulant (argatroban), monitor platelets until they recover above 150,000, then initiate warfarin, and finally stop argatroban after the INR has been therapeutic for 48 hours.
The management of HIT requires a strict multi-step de-escalation and transition protocol. All heparin must be stopped immediately to break the cycle of PF4-antibody complex formation. Because the patient is actively thrombosing, an alternative anticoagulant (e.g., argatroban, bivalirudin, or fondaparinux) must be started empirically without waiting for lab confirmation. The transition to long-term warfarin requires careful monitoring: platelets must first recover to baseline or ≥150,000/mm3\geq 150,000/\text{mm}^3 to avoid warfarin-induced skin necrosis and venous limb gangrene. Once started, warfarin must overlap with the parenteral anticoagulant for at least 55 days, and the parenteral agent is only discontinued when the INR has been therapeutic for 4848 hours.

Adım Adım Çözüm

1
Discontinue heparin
Halts the ongoing formation of heparin-PF4 complexes.
Continuing heparin worsens the immune response and exacerbates thrombosis.
2
Initiate argatroban
Provides immediate, safe anticoagulation.
Patients with HIT are highly prothrombotic and require continuous anticoagulation while avoiding all heparin products.
3
Monitor platelet recovery
Confirms the HIT process is resolving.
Wait for platelets to reach at least 150,000/mm3150,000/\text{mm}^3 to ensure the hypercoagulable state is stabilizing.
4
Initiate warfarin
Begins the transition to long-term oral anticoagulation.
Starting warfarin too early (before platelet recovery) causes a precipitous drop in Protein C, paradoxically worsening hypercoagulability and risking venous limb gangrene.
5
Overlap and discontinue argatroban
Ensures uninterrupted protection against thrombosis.
Warfarin takes several days to achieve full antithrombotic effect. Argatroban must be continued until the INR is therapeutic (2.0−3.02.0-3.0) for at least 4848 hours.

Anahtar Kavram

Management and monitoring sequence of Heparin-Induced Thrombocytopenia (HIT)
Tahmini Süre:1m 30s
Soru 3258Soru →

A 2222-year-old woman is brought to the emergency department 22 hours after intentionally ingesting a large, unknown quantity of acetaminophen tablets. She is currently asymptomatic, with normal vital signs and an unremarkable physical examination. Arrange the following steps in the most appropriate chronological sequence for monitoring, evaluating, and managing this patient's overdose according to standard medical protocols.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is to first wait 44 hours to obtain an interpretable serum level, plot this level on the Rumack-Matthew nomogram, initiate NN-acetylcysteine if the level is above the treatment line, monitor liver chemistries serially during treatment, and finally discontinue the antidote once criteria for resolution are met.
The standard management protocol for acute acetaminophen ingestion requires establishing an accurate peak serum level to guide antidote therapy. Because acetaminophen absorption can be delayed, levels drawn before 44 hours post-ingestion are uninterpretable. Once a valid level is obtained at or after 44 hours, it must be plotted on the Rumack-Matthew nomogram to stratify the patient's risk of hepatotoxicity. If the value falls on or above the treatment line, NN-acetylcysteine (NAC) therapy is initiated to replenish hepatic glutathione stores. While on NAC, the patient requires ongoing monitoring of liver function tests (AST, ALT), coagulation (PT/INR), and renal function to evaluate for subacute hepatic injury. Finally, the treatment is evaluated for discontinuation; NAC can be safely stopped only when the patient is asymptomatic, liver enzymes are normalizing, and the serum acetaminophen level is undetectable.

Adım Adım Çözüm

1
Delay initial serum level until 44 hours post-ingestion
Obtains an accurate reflection of peak absorption
Levels drawn before 44 hours are uninterpretable on the nomogram due to ongoing drug absorption.
2
Plot level on the Rumack-Matthew nomogram
Risk stratification for hepatotoxicity
Determines if the patient's toxic burden warrants antidote therapy.
3
Initiate NN-acetylcysteine (NAC)
Prevents accumulation of the toxic NAPQI metabolite
Provides a glutathione substitute to detoxify the liver if the nomogram indicates high risk.
4
Monitor serial LFTs and coagulation studies
Tracks the evolution of hepatic injury
Detects subacute hepatotoxicity that may develop despite NAC and guides ongoing treatment.
5
Discontinue NAC based on clinical and laboratory criteria
Safe conclusion of therapy
Ensures the toxic threat has completely resolved (undetectable acetaminophen and improving LFTs) before stopping the antidote.

Anahtar Kavram

Monitoring and evaluating treatment in acute acetaminophen overdose relies on delaying initial levels until peak absorption at 44 hours, using the Rumack-Matthew nomogram for risk stratification, and guiding the discontinuation of NN-acetylcysteine with serial liver function monitoring.
Tahmini Süre:1m 30s
Soru 3259Soru →

A 34-year-old woman presents to the clinic to establish primary care. She recently moved to the area and has not seen a physician in three years. She feels well and has no current symptoms. She exercises regularly, does not smoke, and consumes alcohol occasionally. Her family history is significant for a father who was diagnosed with colon cancer at age 42, and a paternal aunt who was diagnosed with breast cancer at age 60. Her mother is alive and healthy. Vital signs include a blood pressure of 118/74 mm Hg, heart rate of 70/min, and a BMI of 23 kg/m². Physical examination is unremarkable. A review of her medical records shows that a Pap smear with human papillomavirus (HPV) co-testing performed one year ago was normal, and a one-time screening for hepatitis C virus antibody was non-reactive. Which of the following is the most appropriate next step in the preventive care of this patient?

Cevabı ve açıklamayı göster

Cevap: Referral for screening colonoscopy

Cevap

Referral for screening colonoscopy
The correct answer is referral for a screening colonoscopy. This patient is at high risk for colorectal cancer due to her father's diagnosis at age 42. According to guidelines from the US Multi-Society Task Force on Colorectal Cancer, individuals with a single first-degree relative diagnosed with colorectal cancer or advanced adenoma before age 60 should undergo screening colonoscopy every 5 years. This screening should begin at age 40, or 10 years younger than the earliest diagnosis in their family, whichever comes first. In this patient's case, 10 years prior to her father's diagnosis is age 32. Since she is currently 34 years old, she is overdue for screening and should be referred for a colonoscopy immediately.

Adım Adım Çözüm

1
Identify the patient's risk factors for colorectal cancer.
The patient has a first-degree relative (father) diagnosed with colorectal cancer at age 42.
Family history dictates the modality and timing of colorectal cancer screening.
2
Apply the appropriate screening guideline for the identified risk level.
For a first-degree relative diagnosed before age 60, screening must start at age 40 or 10 years before the relative's age at diagnosis, whichever is earlier.
This rule ensures early detection in populations with aggressive or early-onset familial cancer patterns.
3
Calculate the indicated screening age for this specific patient.
10 years before the father's diagnosis (age 42) is age 32. Since 32 is earlier than 40, screening should begin at 32.
Determines if the patient is currently due for screening.
4
Determine the appropriate screening modality.
Colonoscopy is required; non-invasive tests like FIT are inappropriate.
High-risk patients require direct visualization to adequately assess and remove precancerous lesions.

Anahtar Kavram

Colorectal cancer screening in high-risk patients (first-degree relative diagnosed at <60 years of age) should begin with a colonoscopy at age 40 or 10 years before the relative's diagnosis, whichever is earlier.
Soru 3260Soru →

A 6868-year-old man is evaluated in the intensive care unit for altered mental status and uncoordinated movements. He was admitted 55 days ago for severe community-acquired pneumonia complicated by septic shock. He was intubated for 33 days and was successfully extubated yesterday. His past medical history is significant for focal impaired awareness seizures, for which he has taken oral phenytoin for the last 44 years. His current medications include intravenous ceftriaxone, subcutaneous enoxaparin, and his home dose of phenytoin, which is administered via a nasogastric tube.

On physical examination, temperature is 37.2∘37.2^{\circ} C (99.0∘99.0^{\circ} F), blood pressure is 110/70110/70 mmHg, and pulse is 8888/min. The patient is lethargic but arousable. Neurologic examination reveals prominent bilateral horizontal nystagmus, dysarthria, and severe dysmetria on finger-to-nose testing.

Serial laboratory studies over the course of his admission are shown below:

ParameterDay 1Day 3Day 5 (Today)Reference Range
Serum albumin3.53.5 g/dL2.62.6 g/dL1.91.9 g/dL3.5−5.03.5-5.0 g/dL
Blood urea nitrogen2222 mg/dL4545 mg/dL6868 mg/dL8−208-20 mg/dL
Serum creatinine1.11.1 mg/dL1.91.9 mg/dL2.82.8 mg/dL0.7−1.30.7-1.3 mg/dL
Total serum phenytoin1111 mcg/mL1313 mcg/mL1515 mcg/mL10−2010-20 mcg/mL

Which of the following is the most appropriate next step in the evaluation or management of this patient's neurologic findings?

Cevabı ve açıklamayı göster

Cevap: Obtain a serum free phenytoin concentration

Cevap

Obtain a serum free phenytoin concentration to accurately assess for medication toxicity in the setting of hypoalbuminemia and acute kidney injury.
The correct answer identifies the need to measure a free phenytoin level. Phenytoin exhibits nonlinear (Michaelis-Menten) kinetics and is highly protein-bound (approximately 90%90\%). When a patient develops severe hypoalbuminemia, the number of binding sites decreases, causing the unbound, pharmacologically active fraction to rise. Furthermore, this patient has acute kidney injury; uremia alters the structural conformation of albumin, further reducing its affinity for phenytoin. Consequently, a total phenytoin level of 1515 mcg/mL in this patient masks a severely elevated free fraction that is causing his classic toxicity symptoms (nystagmus, dysmetria, lethargy). The definitive next step in monitoring is to obtain a free phenytoin concentration.

Adım Adım Çözüm

1
Evaluate the clinical presentation.
The patient has new-onset lethargy, bilateral horizontal nystagmus, dysarthria, and dysmetria.
These are classic, dose-dependent signs of central nervous system toxicity from phenytoin.
2
Analyze the laboratory trends in the context of the medication.
Total phenytoin is 1515 mcg/mL (therapeutic range 10−2010-20 mcg/mL). However, albumin has dropped significantly to 1.91.9 g/dL, and the patient has developed acute kidney injury with uremia (BUN 6868 mg/dL).
Phenytoin is normally 90%90\% bound to albumin. Hypoalbuminemia means there are fewer binding sites, and uremia alters the affinity of existing albumin, both leading to an increased free (unbound, active) fraction of the drug.
3
Determine the appropriate management step.
Order a serum free phenytoin concentration.
Because the total level is misleadingly 'normal', evaluating the free fraction (target 1−21-2 mcg/mL) will confirm the suspected toxicity and guide dosage adjustments.

Anahtar Kavram

In patients with severe hypoalbuminemia or uremia, total serum phenytoin levels are an inaccurate measure of pharmacologic activity because the unbound (free) fraction of the drug increases significantly, necessitating the measurement of free phenytoin levels to diagnose toxicity.

Alternatif Yöntem

Instead of waiting for a free phenytoin lab result (which is a send-out test at many institutions), clinicians can mathematically estimate the adjusted total phenytoin level using the Winter-Tozer equation. For patients with renal failure, the formula is: Adjusted Total Phenytoin = Measured Total / ((0.1 * Albumin) + 0.1). For this patient, the estimated adjusted total level would be 15/((0.1∗1.9)+0.1)=15/0.29≈51.715 / ((0.1 * 1.9) + 0.1) = 15 / 0.29 \approx 51.7 mcg/mL, which massively exceeds the therapeutic upper limit of 2020 mcg/mL.
Tahmini Süre:1m 30s
ÖncekiSayfa 163 / 237Sonraki
Tüm alıştırma soruları — USMLE Step 3 | Examkin